RNA expression of both LONP1 and ClpP were significantly upregulated in a wide range of human cancers, including bladder, breast, colon, kidney, lung, thyroid, uterine, and prostate cancer, compared with normal tissue (Fig. 1A). This evidence concerns the gene LONP1 and prostate carcinoma.